PT Kalbe Farma Tbk (ISX:KLBF) Net Income From Continuing Operations : Rp3,369,450 Mil (TTM As of Mar. 2025)

View and export this data going back to 1991. Start your Free Trial

What is PT Kalbe Farma Tbk Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. PT Kalbe Farma Tbk's net income from continuing operations for the three months ended in Mar. 2025 was Rp1,110,458 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was Rp3,369,450 Mil.

PT Kalbe Farma Tbk Net Income From Continuing Operations Historical Data

The historical data trend for PT Kalbe Farma Tbk's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kalbe Farma Tbk Net Income From Continuing Operations Chart

PT Kalbe Farma Tbk Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income From Continuing Operations

Get a 7-Day Free Trial

2,799,622.52

3,232,007.68

3,450,083.41

2,778,404.82

3,246,569.75

PT Kalbe Farma Tbk Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income From Continuing Operations	Get a 7-Day Free Trial															987,577.72	843,234.62	565,521.86	850,235.55	1,110,457.82

PT Kalbe Farma Tbk Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp3,369,450 Mil.

PT Kalbe Farma Tbk Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Kalbe Farma Tbk (ISX:KLBF) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

PTKFY:USA LCLA:Germany

Address

Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, P.O. Box 3105, Jakarta, IDN, 10510

Website

https://www.kalbe.co.id

PT Kalbe Farma Tbk is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. The majority of the company's gross profits are derived from the distribution and logistics segments. The company operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.

PT Kalbe Farma Tbk Headlines

No Headlines